Transcription of KDIGO Clinical Practice Guideline for the Management of ...
{{id}} {{{paragraph}}}
Example: stock market
KDIGO Clinical Practice Guideline for the Management of ...
Volume 2 | issue 5 | DeCemBeR 2012 JOurnal Of the internatiOnal SOciety Of nephrOlOgyKDIGO Clinical Practice Guideline for the Management of blood pressure in Chronic Kidney DiseaseKDIGO Clinical Practice Guidelinefor the Management of blood pressure inChronic Kidney DiseaseKDIGO gratefully acknowledges the following consortium of sponsors that make our initiatives possible: Abbott, Amgen,Bayer Schering Pharma, Belo Foundation, Bristol-Myers Squibb, Chugai Pharmaceutical, Coca-Cola Company, Dole FoodCompany, Fresenius Medical Care, Genzyme, Hoffmann-LaRoche, JC Penney, Kyowa Hakko Kirin, NATCO TheOrganization for Transplant Professionals, NKF-Board of Directors, Novartis, Pharmacosmos, PUMC Pharmaceutical,Robert and Jane Cizik Foundation, Shire, Takeda Pharmaceutical, Transwestern Commercial Services, Vifor Pharma,and Statement: KDIGO is supported by a consortium of sponsors and no funding is accepted for the developmentof specific Clinical Practice Guideline for the Management of blood Pressurein Chronic Kidney DiseaseTablesvKDIGO Board Memb
347 Chapter 2: Lifestyle and pharmacological treatments for lowering blood pressure in CKD ND patients 357 Chapter 3: Blood pressure management in CKD ND patients without diabetes mellitus 363 Chapter 4: Blood pressure management in CKD ND patients with diabetes mellitus 370 Chapter 5: Blood pressure management in kidney transplant recipients ...
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: